当前吸烟者气道上皮IL-33表达在转录组和蛋白水平均降低
研究探讨吸烟状态对IL-33表达的影响,整合8项气道转录组研究及肺组织蛋白分析,发现当前吸烟者IL-33基因表达和信号通路显著低于已戒烟或从不吸烟者,戒烟后表达回升;单细胞测序显示IL-33主要表达于静息基底上皮细胞,慢性吸烟促使该亚群分化而减少IL-33,蛋白水平亦证实当前吸烟的COPD患者IL-33更低。
要点
- 当前吸烟者气道IL-33基因表达及信号通路显著低于已戒烟或从不吸烟者
- 戒烟后IL-33表达回升,蛋白水平在COPD当前吸烟者中亦更低
- IL-33降低可能与静息基底上皮细胞减少有关,或解释抗IL-33治疗对已戒烟者更有效
核心结论
- 吸烟导致IL-33在转录组和蛋白水平整体降低,可能源于静息基底上皮细胞减少。
- 这一发现或可解释抗IL-33抗体治疗对已戒烟COPD患者比当前吸烟者更有效。
研究设计与样本
- 整合8项独立气道转录组研究分析IL-33基因表达与吸烟状态的关联。
- 对肺组织进行Western blot和免疫组化检测IL-33蛋白水平。
- 利用单细胞测序分析IL-33表达的细胞亚群及吸烟诱导的分化变化。
主要发现
- 在当前吸烟者中,IL-33基因表达及其信号通路显著低于已戒烟或从不吸烟者(P < 0.05)。
- 戒烟后IL-33表达增加(P < 0.05)。
- 单细胞测序显示IL-33主要表达于静息基底上皮细胞,烟雾暴露触发其分化并减少IL-33。
- 慢性吸烟使静息基底上皮细胞向更分化细胞类型转变增加。
- 蛋白分析显示COPD当前吸烟者肺组织IL-33水平低于已戒烟者,当前吸烟对照者IL-33阳性基底细胞比例低于已戒烟对照者。
临床怎么用
- 提示吸烟状态可能影响抗IL-33治疗的疗效,当前吸烟者可能反应较差。
- 临床评估COPD患者IL-33相关治疗时应考虑吸烟状态。
- 戒烟可能恢复IL-33表达,或增强抗IL-33治疗的敏感性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: IL-33 is a proinflammatory cytokine thought to play a role in the pathogenesis of asthma and chronic obstructive pulmonary disease (COPD). A recent clinical trial using an anti-IL-33 antibody showed a reduction in exacerbation and improved lung function in ex-smokers but not current smokers with COPD. Objectives: This study aimed to understand the effects of smoking status on IL-33. Methods: We investigated the association of smoking status with the level of gene expression of IL-33 in the airways in eight independent transcriptomic studies of lung airways. Additionally, we performed Western blot analysis and immunohistochemistry for IL-33 in lung tissue to assess protein levels. Measurements and Main Results: Across the bulk RNA-sequencing datasets, IL-33 gene expression and its signaling pathway were significantly lower in current versus former or never-smokers and increased upon smoking cessation (P < 0.05). Single-cell sequencing showed that IL-33 is predominantly expressed in resting basal epithelial cells and decreases during the differentiation process triggered by smoke exposure. We also found a higher transitioning of this cellular subpopulation into a more differentiated cell type during chronic smoking, potentially driving the reduction of IL-33. Protein analysis demonstrated lower IL-33 levels in lung tissue from current versus former smokers with COPD and a lower proportion of IL-33-positive basal cells in current versus ex-smoking controls. Conclusions: We provide strong evidence that cigarette smoke leads to an overall reduction in IL-33 expression in transcriptomic and protein level, and this may be due to the decrease in resting basal cells. Together, these findings may explain the clinical observation that a recent antibody-based anti-IL-33 treatment is more effective in former than current smokers with COPD.
引用
- Faiz, Mahbub, Boedijono, et al. IL-33 Expression Is Lower in Current Smokers at both Transcriptomic and Protein Levels. Am J Respir Crit Care Med. 2023. PMID: 37708400. doi:10.1164/rccm.202210-1881OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。